Skip to main content

Latest stock market podcasts

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Morning Bell 16 September

Bell Direct
September 16, 2020

Morning Bell 15 September

Bell Direct
September 15, 2020

Morning Bell 14 September

Bell Direct
September 14, 2020

Weekly Wrap 11 September

Bell Direct
September 11, 2020

Morning Bell 11 September

Bell Direct
September 11, 2020

Morning Bell 10 September

Bell Direct
September 10, 2020

Morning Bell 9 September

Bell Direct
September 9, 2020

Morning Bell 8 September

Bell Direct
September 8, 2020

Morning Bell 7 September

Bell Direct
September 7, 2020

Weekly Wrap 4 September

Bell Direct
September 4, 2020

Morning Bell 4 September

Bell Direct
September 4, 2020